Atlas Trials

A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Clinical trial NCT00975481 · COMPLETED

Trial details

NCT number
NCT00975481
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseHuntington's Disease
Start date
2009-10-01
Primary completion
2010-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.